Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Accumulated Depreciation & Amortization (2016 - 2017)

Historic Accumulated Depreciation & Amortization for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $333.0.

  • Bone Biologics' Accumulated Depreciation & Amortization rose 5067.87% to $333.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $333.0, marking a year-over-year increase of 5067.87%. This contributed to the annual value of $261.0 for FY2016, which is N/A changed from last year.
  • Bone Biologics' Accumulated Depreciation & Amortization amounted to $333.0 in Q3 2017, which was up 5067.87% from $309.0 recorded in Q2 2017.
  • Bone Biologics' 5-year Accumulated Depreciation & Amortization high stood at $333.0 for Q3 2017, and its period low was $221.0 during Q3 2016.